H.B. Fuller Announces Offer to Acquire Advanced Medical Solutions
H.B. Fuller Announces Offer to Acquire Advanced Medical Solutions
Extends capabilities in attractive, high-growth medical segments
Accelerates portfolio mix shift and path to >20% EBITDA margin target
Expected to deliver ~$55 million in run-rate synergies
H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world’s largest pureplay adhesives company, today announced it has made a recommended cash offer to acquire Advanced Medical Solutions Group plc (“AMS”) (LSE:AMS).
H.B. Fuller Investors Weigh Big Advanced Medical Cash Offer, Stock Tanks - H.B. Fuller (NYSE:FUL)
H.B. Fuller nears a $628 million deal for UK wound-care maker AMS, over its own investor’s objections
US glue maker swoops on AIM-listed manufacturer in £659m deal
AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs
Achieve Life Sciences gets a CRL; UPS invests $48M in healthcare logistics
H.B. Fuller shares fell premarket as investors weighed its AMS acquisition, Q2 earnings beat, raised guidance and cash position.
H.B. Fuller has agreed a 285p-a-share cash offer for AMS, valuing its equity near $628m, as activist Ancora urges the board to…
HB Fuller made a swoop for AIM-listed Advanced Medcial Solutions, in a deal that values it at around £659m.
H.B. Fuller Sets 2030 Sustainability Targets, With Nearly 60% of Innovation Focused on Sustainable Solutions
H.B. Fuller Reports Second Quarter 2026 Results
H.B. Fuller to Report Second Quarter 2026 Results on June 24, 2026
